These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 29865239)

  • 1. Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines.
    Berti F; De Ricco R; Rappuoli R
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29865239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial polysaccharides as vaccines--immunity and chemical characterization.
    Lee CJ; Lee LH; Lu CS; Wu A
    Adv Exp Med Biol; 2001; 491():453-71. PubMed ID: 14533815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyosides (encapsulated bacteria).
    Lindberg AA
    C R Acad Sci III; 1999 Nov; 322(11):925-32. PubMed ID: 10646085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical studies on new proteins as carrier for glycoconjugate vaccines.
    Tontini M; Romano MR; Proietti D; Balducci E; Micoli F; Balocchi C; Santini L; Masignani V; Berti F; Costantino P
    Vaccine; 2016 Jul; 34(35):4235-4242. PubMed ID: 27317455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate-Based Vaccines: An Overview.
    Hütter J; Lepenies B
    Methods Mol Biol; 2015; 1331():1-10. PubMed ID: 26169731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated polysaccharide vaccines.
    Ahmad H; Chapnick EK
    Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.
    Tacket CO; Ferreccio C; Robbins JB; Tsai CM; Schulz D; Cadoz M; Goudeau A; Levine MM
    J Infect Dis; 1986 Aug; 154(2):342-5. PubMed ID: 2425009
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation.
    Fusco PC; Farley EK; Huang CH; Moore S; Michon F
    Clin Vaccine Immunol; 2007 May; 14(5):577-84. PubMed ID: 17376859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with Salmonella typhi Vi capsular polysaccharide vaccine.
    Hessel L; Debois H; Fletcher M; Dumas R
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):609-20. PubMed ID: 10534182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay.
    de Voer RM; Schepp RM; Versteegh FG; van der Klis FR; Berbers GA
    Clin Vaccine Immunol; 2009 Mar; 16(3):433-6. PubMed ID: 19129470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conjugated vaccines].
    Fritzell B
    Therapie; 2005; 60(3):249-55. PubMed ID: 16128267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal Models.
    Micoli F; Alfini R; Di Benedetto R; Necchi F; Schiavo F; Mancini F; Carducci M; Oldrini D; Pitirollo O; Gasperini G; Balocchi C; Bechi N; Brunelli B; Piccioli D; Adamo R
    Front Immunol; 2021; 12():719315. PubMed ID: 34594333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis.
    Cripps AW; Foxwell R; Kyd J
    Curr Opin Immunol; 2002 Oct; 14(5):553-7. PubMed ID: 12183152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies.
    Ozdilek A; Huang J; Babb R; Paschall AV; Middleton DR; Duke JA; Pirofski LA; Mousa JJ; Avci FY
    mBio; 2021 Jun; 12(3):e0080021. PubMed ID: 34061603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
    Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs.
    Berti F; Micoli F
    Curr Opin Immunol; 2020 Aug; 65():42-49. PubMed ID: 32361591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR assays for carbohydrate-based vaccines.
    Jones C
    J Pharm Biomed Anal; 2005 Aug; 38(5):840-50. PubMed ID: 16087046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of O-acetyl and phosphoglycerol groups for the antigenicity of Streptococcus pneumoniae serotype 18C capsular polysaccharide.
    Chang J; Serrano Y; Garrido R; Rodríguez LM; Pedroso J; Cardoso F; Valdés Y; García D; Fernández-Santana V; Verez-Bencomo V
    Vaccine; 2012 Nov; 30(49):7090-6. PubMed ID: 23036500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.